East & Concord Partners

Follow

Issues to note when a parent absorbs a wholly owned subsidiary by merger

October 6 2015 There are a number of methods that a merger and restructuring may take, such as equity transfer, asset transfer, investing in other enterprises…

母公司吸收合并全资子公司的注意问题

October 6 2015 兼并重组包括多种方式,如股权或资 产的转让、以增资方式对其他企业 进行投资、企业之间的合并分立等。本文 将介绍母公司吸收合并全资子公司应该关 注的几个法律问题。文中所指公司为有限 责任公司。 母公司注册资本 从表面上看,公司合并似乎是合并方与 被合并方之间的关系,但实质上却是股东…

美国法律的域外适用和影响

July 5 2019 近年来,美国法律在全球的影响力越来越大,管辖范围越来越广,对美国域外的交易和交易主体都产生了重大影响…

Using valuation adjustment mechanisms in M&A deals

October 6 2015 Valuation adjustment mechanisms, or VAM agreements, have been employed in mergers and acquisition deals. VAM agreements were first used in private…

民事诉讼中的律师调查令

July 15 2019 资讯律师调查令在民事诉讼程序中运用的法律依据主要来自于《民事诉讼法》第64条的规定:“当事人及其诉讼代理人因…

In brief: digital healthcare in China

December 6 2022 A look at some of the key issues surrounding the digitisation of the healthcare sector in China, including data protection and privacy concerns.

Snapshot: medicine and medical device pricing in China

December 6 2022 A brief look at some of the key issues surrounding the pricing of medicinal products and medical devices in China.

Q&A: marketing authorisation for pharmaceuticals and medical devices in China

October 8 2022 This article answers some of the key legal and practical questions surrounding the grant of marketing authorisation for pharmaceuticals and medical devices in China.

Q&A: the promotion and sale of pharmaceuticals and medical devices in China

October 8 2022 This Q&A covers the essential legal and practical considerations surrounding the promotion and sale of pharmaceuticals and medical devices in China.

In brief: regulation of healthcare M&A in China

September 14 2022 This article highlights the key legal and regulatory issues surrounding healthcare M&A in China, including merger control and required consents, notifications and filings.